Profil
Gary Allenby is the founder and current Chief Executive Officer of Aurelia Bioscience Ltd, which was founded in 2003.
Aktive Positionen von Gary Allenby
| Unternehmen | Position | Beginn |
|---|---|---|
Aurelia Bioscience Ltd.
 Aurelia Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Aurelia Bioscience Ltd. operates as pre-clinical contract Research Company which engages in biochemical and call based compound screening. The firm specializes in bioassay development, high throughput screening of compounds, label free phenotypic bio screening, FLIPR, FMAT, Envision, Enspire technology, Drug screening instrument and reagents consultancy. The company was founded by Gary Allenby, Kathy Dodgson and Kevin Hart in 2003 and is headquartered in Nottingham, the United Kingdom. | Vorstandsvorsitzender | 01.01.2003 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Aurelia Bioscience Ltd.
Aurelia Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Aurelia Bioscience Ltd. operates as pre-clinical contract Research Company which engages in biochemical and call based compound screening. The firm specializes in bioassay development, high throughput screening of compounds, label free phenotypic bio screening, FLIPR, FMAT, Envision, Enspire technology, Drug screening instrument and reagents consultancy. The company was founded by Gary Allenby, Kathy Dodgson and Kevin Hart in 2003 and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
